Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

Monday, Mar 16, 2026 12:31 pm ET1min read
ALT--

Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

Altimmune:HC Wainwright & Co. raises PT to $25, maintains Buy rating.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet